AMANDA FADENRECHT: Open Payments
NPI 1023425386 · PUEBLO WEST, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 49 payments from 12 companies in 2025. Trend: 2023 $339 · 2024 $724 · 2025 $969
Food & beverage: $969
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $192 |
| GlaxoSmithKline, LLC. | 8 | $174 |
| PFIZER INC. | 9 | $147 |
| Novo Nordisk Inc | 9 | $138 |
| ABBVIE INC. | 5 | $89 |
| Lilly USA, LLC | 3 | $73 |
| Aimmune Therapeutics, Inc. | 2 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Corcept Therapeutics | 1 | $25 |
| Exact Sciences Corporation | 1 | $15 |
Products named: AREXVY, NURTEC ODT, FARXIGA, KISUNLA, Wegovy, VRAYLAR, Ozempic, ZENPEP.
Industry payments across CO — which companies pay providers there.
